|
|
Delscience.com will provide you with comprehensive analysis of particular niches of the biopharmaceutical sector. Our news and reports - multiclient and /or ad hoc - will allow you to know competing products, identify development opportunities, assess potential partners or examine competitors' capabilities.
At the present time, information and intelligence services are focused on nanomedicine and drug delivery. If you are interested in developing or investing in drug delivery technologies, please register above to receive email updates on future services on Delscience.com.
Using DelScience's services, you will gain essential information that will improve your strategic decision making process. If you would like to know how DelScience may be of use to your company or research group, please go to Contact us section or email us.
DelScience's team
|
|
|
DelScience's company profile report will provide the information and analysis you need on Elan Corp. to gain an understanding of what makes the company one of the drug delivery market leaders. |
|
|
QLT, Inc. recently announced it intended to stop investing in new products and technologies and would instead explore all strategic alternatives including selling the company to a third party. DelScience's company profile report will provide the information and analysis you need on QLT to gain an understanding of what made the company one of the drug delivery market leaders in the past, and what led it to the current situation. |
|
|
